High Ground Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263M Buy
679,904
+335,760
+98% +$125M 23.09% 1
2026
Q1
$101M Buy
344,144
+18,063
+6% +$5.94M 18.7% 3
2025
Q4
$114M Buy
326,081
+36,849
+13% +$12.5M 16.64% 4
2025
Q3
$93.5M Buy
289,232
+46,390
+19% +$14.4M 15.53% 3
2025
Q2
$94.5M Buy
242,842
+20,812
+9% +$8.37M 19.8% 3
2025
Q1
$96.6M Buy
222,030
+13,020
+6% +$5.23M 22.55% 3
2024
Q4
$77.1M Buy
209,010
+140,640
+206% +$58.9M 23.92% 3
2024
Q3
$35.6M Hold
68,370
16.38% 3
2024
Q2
$37M Buy
68,370
+5,000
+8% +$2.64M 14.44% 2
2024
Q1
$32.9M Hold
63,370
15.77% 3
2023
Q4
$29.9M Buy
63,370
+500
+0.8% +$231K 14.73% 2
2023
Q3
$27.4M Buy
62,870
+2,000
+3% +$907K 18.24% 2
2023
Q2
$27M Buy
60,870
+2,595
+4% +$1.2M 21.32% 2
2023
Q1
$26.8M Buy
58,275
+3,000
+5% +$1.43M 26.09% 2
2022
Q4
$28.4M Buy
+55,275
New +$28.1M 26.77% 2

Other funds holding ELV

High Ground Investment Management's ELV Position: Q2 2026 in Review

High Ground Investment Management increased its Elevance Health (ELV) stake by 98% in Q2 2026, buying an estimated $125M and bringing the position to 679,904 shares worth $263M. The position accounts for 23.09% of the portfolio, ranked #1.

High Ground Investment Management first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. 368 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • High Ground Investment Management held 679,904 shares of Elevance Health worth $263M as of Q2 2026.
  • High Ground Investment Management bought 335,760 Elevance Health shares in Q2 2026, an estimated $125M.
  • Elevance Health made up 23.09% of High Ground Investment Management's portfolio in Q2 2026, its #1 holding.
  • High Ground Investment Management first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • 368 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on High Ground Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.